Purchase Order N3239822P0204
- Not listed
- This federal contract award is for the delivery of SureScan Microarray products by Agilent Technologies Inc. to the Bureau of Medicine and Surgery, a Defense agency. The contract has a ceiling value of $123,112.14 and is a firm fixed price delivery order awarded under Agilent's existing Scientific Equipment and Services schedule contract with the General Services Administration. The contract does not have a set-aside designation. Agilent Technologies Inc. is the prime contractor, and no...
- Agilent Technologies Inc., headquartered in Santa Clara, California, was awarded a $205,248.35 firm fixed-price purchase order by the Bureau of Medicine and Surgery (a division of the Department of Defense) on May 21, 2025, for an RTCA eSOIGHT instrument bundle. The contract, with an ultimate completion date of June 20, 2025, carries no set-aside designation and represents a competitively awarded procurement. The place of performance is identified as Marshallton, Delaware. Agilent's Customer...
- Agilent Technologies Inc., a global leader in advanced analytical instrumentation and laboratory services, was awarded a $41.7K purchase order by the Bureau of Medicine and Surgery (Defense) on December 23, 2025, for a TapeStation instrument with an ultimate completion date of February 27, 2026. This firm fixed-price contract, placed of performance in Frederick, Maryland, represents a direct procurement through full and open competition with no set-aside designation. The TapeStation is a...
- This federal contract award, valued at $46,648.22, was issued by the Defense Health Agency to Agilent Technologies Inc. for the procurement of laboratory reagents. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed-price pricing type. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing a range of analytical instruments, software, services, and consumables to federal agencies. The company has a strong track...
- This federal contract award was issued by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Agilent Technologies Inc. Customer Service And Sales Division. The $81,830.04 fixed-price delivery order is for the provision of a 2100 Bioanalyzer, a scientific instrument used for protein and nucleic acid analysis. The contract is under the Scientific Equipment and Services master schedule (FSS-66) of the General Services Administration. It does not have a set-aside...
- This federal contract award is for $20,805.00 and was issued by the Defense Health Agency to Agilent Technologies Inc. The contract is a BPA Call (Blanket Purchase Agreement) for the procurement of REAGENTS. The contract has a firm fixed price pricing type and an ultimate completion date of September 30, 2025. The contract does not have a set-aside designation, indicating it was competed on a full and open basis. Agilent Technologies Inc. is a global leader in life sciences, diagnostics, and...
- This federal contract award to Agilent Technologies Inc.'s Customer Service and Sales Division is a Firm Fixed Price purchase order from the Northeast Area of the U.S. government's civilian agencies. The $8,352 contract has a completion date of September 14, 2016 and was awarded on September 10, 2015. Agilent is a global leader in life sciences, diagnostics, and applied chemical markets, providing analytical instruments, software, services, and expertise to federal agencies such as NIH, FDA,...
- The Defense Health Agency awarded Agilent Technologies Inc. a $16,042.50 firm fixed-price Blanket Purchase Agreement (BPA) call on July 31, 2025, for high sensitivity next-generation sequencing (NGS) fragment analysis kits capable of processing DNA fragments between 1 and 6,000 base pairs, with a total volume of 500 samples. The contract is set to be completed by September 30, 2025, and will be performed at Agilent's facility in Marshallton, Delaware. This award represents a task order under...
- Agilent Technologies Inc. Customer Service and Sales division was awarded a purchase order contract on August 16, 2018, for a G8830A Ariamx Real-Time PCR System with a firm fixed price ceiling value of $23,629.20. The contract, which utilizes no set-aside designation and indicates full and open competition, was awarded by a civilian federal agency (Southeast Area) for delivery to Marshtonville, Delaware, with an ultimate completion date of September 30, 2018. This purchase order represents a...
- This is a firm fixed price delivery order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Agilent Technologies Inc. Customer Service And Sales Division, a subsidiary of Agilent Technologies, Inc. The contract is for an AGILENT 6545 SERVICE CONTRACT for the base year, with a ceiling value of $34,459.56. The contract was awarded on October 15, 2019 and has an ultimate completion date of September 29, 2020. This contract was awarded under...
Agilent Technologies Inc. was awarded a purchase order valued at $10,220.00 by the Bureau of Medicine and Surgery (a Defense agency) on August 29, 2022, for a high sensitivity DNA chip. This firm fixed-price contract, which is not set-aside designated, indicates full and open competition and must be completed by November 30, 2022. The contract is being performed in Peru and represents a child contract under Agilent Technologies, Inc. headquarters division, reflecting the company's established role as a key supplier of specialized laboratory and diagnostic equipment to federal health agencies. This award aligns with Agilent's broader federal contracting portfolio, which demonstrates significant experience supplying advanced analytical instruments and diagnostic technologies to Department of Defense and Department of Veterans Affairs health networks. Agilent holds multiple indefinite delivery contracts valued up to $749,000 for immunohistochemistry staining systems and related laboratory reagents across Veterans Integrated Service Networks. The DNA chip procurement supports the Bureau of Medicine and Surgery's medical research and diagnostic capabilities, leveraging Agilent's expertise in high-sensitivity analytical instrumentation that serves critical federal healthcare missions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.2k | 8/29/22 |